AGO2 and viral infectious disease: To confirm whether the lack of p53 inhibits AGO2 translocation to the nucleus upon viral infection, we generated TP53 knockout (KO) HEK293 cells by CRISPR-CAS9 (Supplementary Fig. 4A).